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Mosquito-transmitted arboviruses constitute a large proportion of emerging infectious diseases 24 
that are both a public health problem and a threat to animal populations. Many such viruses were 25 
identified in East Africa, a region where they remain important and from where new arboviruses 26 
may emerge. We set out to describe and review the relevant mosquito-borne viruses that have 27 
been identified specifically in Uganda. We focused on the discovery, burden, mode of 28 
transmission, animal hosts and clinical manifestation of those previously involved in disease 29 
outbreaks. A search for mosquito-borne arboviruses detected in Uganda was conducted using 30 
search terms “Arboviruses in Uganda” and “Mosquitoes and Viruses in Uganda” in PubMed and 31 
Google Scholar in 2020. Twenty-four mosquito-borne viruses from different animal hosts, 32 
humans and mosquitoes were documented. The majority of these were from family 33 
Peribunyaviridae, followed by Flaviviridae, Togaviridae, Phenuiviridae and only one each from 34 
family Rhabdoviridae and Reoviridae. Sixteen (66.7%) of the viruses were associated with febrile 35 
illnesses. Ten (41.7%) of them were first described locally in Uganda. Six of these are a public 36 
threat as they have been previously associated with disease outbreaks either within or outside 37 
Uganda. Historically, there is a high burden and endemicity of arboviruses in Uganda. Given the 38 
many diverse mosquito species known in the country, there is also a likelihood of many 39 
undescribed mosquito borne viruses. Next generation diagnostic platforms have great potential 40 
to identify new viruses. Indeed, four novel viruses, two of which were from humans (Ntwetwe 41 
and Nyangole viruses) and two from mosquitoes (Kibale and Mburo viruses) were identified in 42 
the last decade using next generation sequencing. Given the unbiased approach of detection of 43 
viruses by this technology, its use will undoubtedly be critically important in the characterization 44 
of mosquito viromes which in turn will inform other diagnostic efforts. 45 







Mosquito-borne arboviruses constitute an important proportion of emerging infectious diseases 52 
that are a global threat to the human and animal populations (1-5). About 167/300 (55.7%) of 53 
the viruses in “The Arthropod borne viruses of vertebrates”, a book that gives an account of the 54 
activities of the Rockefeller Foundation program were listed as transmitted by mosquitoes (6). 55 
The rest of the viruses are transmitted by either ticks, mites, sandflies or biting midges. Over 530 56 
arboviruses are listed in the CDC Arbovirus catalogue, with majority of the mosquito borne 57 
viruses found in the Togaviridae, Flaviviridae, Rhabdoviridae, Reoviridae families; as well as 58 
families in the recently created order Bunyavirales (7, 8).  59 
Surveillance for mosquito-borne viruses and vector species in Uganda began in the mid 1930s 60 
and were carried out by the Yellow Fever Research Institute (YFRI), the Medical Department of 61 
Uganda Protectorate and the Rockefeller Foundation (9, 10). The main objective at that time was 62 
to ascertain whether yellow fever virus (YFV, family Flaviviridae) was actively transmitted in East 63 
Africa and if so determine the extent of spread eastwards from West Africa (11). In the course of 64 
these investigations, West Nile virus (WNV, family Flaviviridae) and Bwamba virus (BWAV, family 65 
Peribunyaviridae) were isolated from North-Western Uganda and Western Uganda (12, 13). 66 
Further countrywide surveys to determine the endemicity of yellow fever led to the discovery of 67 
many other viruses including Semliki Forest virus (SFV, family Togaviridae), Bunyamwera virus 68 
(BUNV, family Peribunyaviridae), Ntaya virus (NTAV, family Flaviviridae) and Uganda S (UGSV, 69 
family Flaviviridae) (14-18). By 1947, a total of 10 viruses had been isolated and characterized 70 
(19, 20). In 1950, the mandate of the YFRI -now the Uganda Virus Research Institute (UVRI)- was 71 
expanded to search for all possible viruses that might be endemic in the region. Since then, over 72 
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20 arboviruses were described (11, 21). Some of the viruses locally described in Uganda have 73 
emerged in other parts of the world and evolved into additional genotypes and lineages 74 
associated with morbidity and mortality (22, 23). Although a number of viruses were described 75 
in the past, recent technological advances in diagnostic tools have led to an increased number of 76 
viruses and outbreaks identified, which could not be identified by available traditional methods 77 
(24-27). Here we aimed to update and summarize the current knowledge of mosquito-borne 78 
arboviruses that have been identified in Uganda. This is of interest both from a historical point of 79 
view, given the importance of the country in the history of arbovirology, but also informative for 80 
current preventive efforts in the region. 81 
 82 
Overview and analysis of published records  83 
A search for all mosquito-borne arboviruses detected in Uganda was conducted by inserting the 84 
search terms “Arboviruses in Uganda” or “Mosquitoes and Viruses in Uganda” into PubMed 85 
(https://pubmed.ncbi.nlm.nih.gov) and Google Scholar (https://scholar.google.com/), last 86 
accessed on 13th July 2020. Only original research articles that involved work done in Uganda 87 
were eligible for review. The first search term (“Arboviruses in Uganda”) yielded a total of 56 88 
publications 16 of which were eligible, and the second search term (“Mosquitoes and Viruses in 89 
Uganda”) yielded 111 articles, 49 of which were eligible. We excluded all articles that were not 90 
primary research articles and those that listed no arboviruses. We also cross-checked for 91 
arboviruses in other secondary databases including the International Committee of Taxonomy 92 
for Viruses, the Centers for Disease Control and Prevention Arbovirus-Catalog and Virus Pathogen 93 
Database and Analysis Resource.  94 
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A total of 24 mosquito-borne viruses -WNV, BWAV, YFV, BUNV, NTAV, SFV, UGSV, Zika virus (ZIKV, 95 
family Flaviviridae), chikungunya virus (CHIKV, family Togaviridae), Rift Valley fever virus (RVFV, 96 
family Phenuiviridae), o’nyong nyong virus (ONNV, family Togaviridae), Nyando virus (NDOV, 97 
family Peribunyaviridae), Orungo virus (ORUV, family Reoviridae), Babanki virus (BBKV, family 98 
Togaviridae), PGAV (family Peribunyaviridae), Sindbis virus (SINV, family Togaviridae), Germiston 99 
virus (GERV, family Peribunyaviridae), Usutu virus (USUV, family Flaviviridae), Tanga virus (TANV, 100 
family Peribunyaviridae), Wesselsbron virus (WSLV, family Flaviviridae), Arumowot virus (AMTV, 101 
family Phenuiviridae), Mossuril virus (MOSV, family Rhabdoviridae), WITV (family 102 
Peribunyaviridae), and Kamese virus (KAMV, family Rhabdoviridae) from different animal hosts 103 
including humans and mosquitoes were documented. Out of the 24 viruses, 8 (33.3 %), were 104 
from the family Peribunyaviridae, followed by 7 (29.2 %) Flaviviridae, 5 (20.8 %) Togaviridae, 2 105 
(8.3 %) Phenuiviridae and 1 (4.2 %) each from the Rhabdoviridae and Reoviridae. 16/24 (66.7 %) 106 
are associated with febrile illnesses in humans with 8 of these majorly vectored by Aedes species, 107 
5 by Culex species and 3 by Anopheles species (Figure 1, Supplementary Table 1). 108 
10 (41.7%) of these viruses (WNV, BWAV, BUNV, ZIKV, UGSV, NTAV, SFV, ONNV, ORUV and KAMV 109 
were first described locally in Uganda (12, 13, 18, 19, 28-30). 6 of the viruses (WNV, BWAV, ONNV, 110 
ZIKV, YFV and RVFV) are public health threats, as they have been previously associated with 111 
disease outbreaks either within or outside Uganda (3, 31-35). YFV and CHIKV, although not first 112 
isolated in Uganda, are highly endemic and associated with several outbreaks in the country (4, 113 
36-40). This information is summarized in Table 1. 114 
In recent years more viruses were identified, in line with increased surveillance and improved 115 
detection methods. Discovery data relate to specific areas of Uganda, as indicated in Figure 2. 116 
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The figure also shows that earlier studies were mainly conducted in the Western and Central 117 
regions. This was partly due to the yellow fever endemicity described in these areas at the time. 118 
Out of the five viruses associated with outbreaks (Table 1), RVFV had the highest number of 119 
papers recorded (13), followed by YFV (8), ONNV (3) and fewer reported for CHIKV (2) and BWAV 120 
(2). The majority of these outbreaks were documented in the Central and Western regions of 121 
Uganda. Transmission to humans occurs following the bite of infected Aedes, Culex or Anopheles 122 
mosquito species. BWAV and ONNV, transmitted by An. gambiae and An. funestus, show a 123 
geographical distribution limited only to the African continent. Below we summarize the number 124 
of disease outbreaks, the prevalence and case fatality associated with selected mosquito borne 125 
arboviruses. 126 
 127 
Viruses previously involved in disease outbreaks in Uganda 128 
Bwamba virus  129 
BWAV (family: Peribunyaviridae, genus: Orthobunyavirus), a virus transmitted by An. gambiae 130 
and An. funestus mosquitoes, was first reported during an epidemic in a small village setting in 131 
Bwamba County, Western Uganda (12, 20, 41). The virus was isolated from African labourers 132 
working on the road construction project to Bwamba county. It was isolated by inoculation of 133 
human serum into mice, during this epidemic, nine strains of the virus were isolated (42). Victims 134 
presented with low grade pyrexia for 2 to 5 days, headache, backache and this was followed by 135 
rapid recovery (19). Later, it was isolated from Aedes and Mansonia species in the same county 136 
(19, 33, 41). Infection is characterized by meningitis, myocarditis, diarrhea, headache, skin rash 137 
and joint pains lasting for 4 to 5 days (12, 41). The general prevalence of BWAV in Uganda was 138 
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estimated to be around 57.8 %, however this may vary from place to place (19). A survey in 1952  139 
within the local people of the East African region showed 70.5 % seropositivity in Bwamba county 140 
while in Tanga region of Tanzania it was 80.1 % (42). Since then, little was heard of BWAV until 141 
forty years later, when three strains were isolated in South-Western Uganda. Isolation was made 142 
in people, one was a refugee from North Eastern Tanzania, another a health worker at UVRI 143 
working with the Rakai project on HIV, while the third strain was from a pool of An. funestus 144 
mosquitoes (33). Although the disease is wide spread, it often presents with mild symptoms 145 
sometimes mistaken for malaria and no fatalities have ever been documented. An animal 146 
reservoir has not been well characterized, but antibodies to BWAV have been found in several 147 
animal hosts including birds, monkeys, donkeys, rodents and domestic animals (41). 148 
West Nile virus 149 
WNV (family: Flaviviridae, genus: Flavivirus), a neurotropic virus antigenically related to Japanese 150 
encephalitis virus (JEV) and St. Louis encephalitis virus (SLEV), was first described in a febrile 151 
female patient in the West Nile district of Uganda (13). Initial serological testing of the patient 152 
serum for YFV antibodies was negative, however intra-cerebral inoculation of serum in new born 153 
mice led to the isolation of a new virus, later named WNV after the West Nile district (13). While 154 
conducting extensive ecological studies in Egypt, Williams and Taylor described the role of birds 155 
in the maintenance of WNV in nature (43, 44). In 1955, sera collected from wild birds and tested 156 
revealed neutralizing antibodies to WNV in Uganda (45). Serological tests in several animal hosts 157 
confirmed domestic fowl, migratory birds and equines as possible reservoirs of WNV (46). The 158 
incubation period for disease in humans ranges from 2 to 14 days (47). Infection is characterized 159 
by the onset of fever, headache, backache, anorexia, neurological disorders, conjunctival 160 
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inflammation, myalgia, arthralgia, skin rash which may persist up to one week, lymphadenopathy 161 
and myocarditis (47). In severe cases, it may present with evidence of encephalitis manifested by 162 
tremors, stiff neck, loss of vision, paralysis, coma and death. WNV is maintained in an enzootic 163 
cycle by Culex mosquitoes and some Coquillettidia species, while birds are amplifying hosts with 164 
equines sometimes being incidental hosts (Figure 1). During routine mosquito collections and 165 
sero-surveys in Uganda, the virus has been isolated from pools of Cq. metallica, Cq. aurites and 166 
Cx. neavei and humans (48-50). During blood feeding, Culex mosquitoes acquire infection from 167 
animal reservoirs, and on subsequent feedings, the mosquito secretes saliva which contains the 168 
virus to infect other animal hosts. Spillover to human hosts occurs when infected mosquito 169 
vectors that have acquired infection from animal/bird hosts and pass it on to humans on 170 
subsequent feedings. The virus has now been detected in many parts of Africa, Middle East and 171 
Europe and in 1999 was described for the first time in North America (3, 51).  172 
Yellow fever virus  173 
YFV (family: Flaviviridae, genus: Flavivirus) is of specific importance as much arbovirus research 174 
in Uganda was initiated specifically because of this pathogen. It is a mosquito-borne virus that 175 
may cause hemorrhagic fever and jaundice with a high associated mortality (40). Country wide 176 
surveys to determine the mosquito vectors, transmission and biology of YFV were started in the 177 
mid 1930s. During those surveys, one of the three well described YFV transmission cycles, the 178 
sylvatic cycle, in which Ae. africanus is involved, was discovered in western Uganda (10, 52). In 179 
this cycle also known as the jungle or forest cycle, YFV is maintained endemically with Ae. 180 
africanus as the main vector for transmission between simian hosts such as monkeys, 181 
chimpanzees, baboons and bush babies (Figure 1). Once in a susceptible monkey population, the 182 
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virus may at times cause an epizootic resulting in death of monkeys. Ae. africanus is mainly active 183 
between sunset and sunrise and often bites at > 50 ft above the ground. The other two YFV 184 
transmission cycles are the urban and intermediate cycles. The urban cycle involves 185 
anthropophilic Ae. aegypti aegypti populations which prefer human blood, oviposit their eggs in 186 
artificial containers and mainly bite indoors. However, records show that significant variations 187 
exist within the Ae. aegypti populations. In Uganda, Ae. aegypti populations are mainly zoophilic 188 
(Ae. aegypti formosus), outdoor dwelling and less competent to virus transmission, thus the 189 
urban YFV transmission cycle has not been documented in Uganda (53, 54).  190 
The YFV intermediate cycle in Uganda involves Ae. bromeliae a sub species of Ae. simpsoni 191 
complex that inhabits and breeds in garden plantations (mainly banana and Colocasia). During 192 
feeding, Ae. bromeliae can be infected with YFV from infected monkeys and other non-human 193 
primates that have raided garden plantations in search for food and transmit it to humans during 194 
subsequent feedings (55). Published literature on the history of yellow fever outbreaks in 195 
Uganda, the distribution of YFV vectors and the country wide serosurveys since the inception of 196 
yellow fever activities are summarized in Table 2. 197 
The first human case of YFV described in Uganda was a 27 year old female African from Bwamba 198 
county in Western Uganda (10). She presented with symptoms of meningitis including severe 199 
headache, high temperature (40.3oC) and neck pain. Virus isolation attempts revealed Ae. 200 
simpsoni as the main mosquito vector, with Eretmopodites chrysogaster and Ae. africanus 201 
implicated in virus transmission (10). The first documented YFV outbreak in Uganda was in 1941 202 
in Bwamba county. A serological survey in this area showed 28.6 % of the human population had 203 
been infected (10). In order to prevent further spread of the disease East wards to Toro district, 204 
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a mass vaccination program was instituted by the Medical Department of the Uganda 205 
Government.  In 1950, a survey in the West Nile district showed that 18 % of the population in 206 
Midigo, with 36 % of the monkeys had been exposed to the YFV (56). Since then, several 207 
autochthonous outbreaks have been reported mainly in the western and central regions of the 208 
country. In 1952, a fatal case due to YFV in a European worker occurred around Fort Portal in 209 
Western Uganda (57). Infection was detected in Ae. africanus and monkey hosts near the 210 
residence of the deceased individual. In 1964, another fatal outbreak occurred in Central Uganda, 211 
25 miles away from Kampala on the Hoima road(58). At the time of death, the victim had deep 212 
jaundice and gross albuminuria. YFV was confirmed through isolation from the cerebral-spinal 213 
fluid, histological examination of the liver tissue; and isolation from three pools of Ae. africanus 214 
(58, 59). A countrywide survey showed YFV range from 1/103 (0.97 %) in North-Eastern through 215 
6.4% in Central to 34.2 % in Western Uganda (60). In 1943, an epizootic occurred in non-human 216 
primates on Bukasa islands where the prevalence of YFV was 88.9 % (61). Related studies done 217 
in 1972 showed that another epizootic had occurred in the monkey population in the Zika Forest, 218 
where the prevalence was 40 % (62). In 2010, an outbreak of a viral hemorrhagic fever (VHF) 219 
characterized by high fever, convulsions, vomiting, bleeding through body orifices and finally 220 
death occurred in Northern Uganda (40). Serological and molecular testing for the common 221 
circulating VHFs including Ebola, Marburg, RVFV and Crimean Congo Hemorrhagic Fever at 222 
Special pathogens UVRI tested negative. Further screening of samples at partner institution CDC 223 
(Atlanta, GA, USA) using NGS revealed 92 % homology to YFV (27, 40). Further laboratory tests -224 
carried out after this confirmation- at UVRI; including IgM, PRNT and PCR using primers 225 
developed to target the YFV East African genotype- revealed 7.5% of the suspected cases to be 226 
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positive (27, 40). Case fatality during this outbreak was (45 deaths) 24.9% (40). The latest 227 
documented YFV outbreak occurred in the central and south-western parts of Uganda, in which 228 
case fatality was 33 % (63) . Although in other parts of the world, YFV was controlled through 229 
massive vaccination campaigns and control of vector species, this remains a challenge as 230 
vaccination is not mandatory in Uganda other than in international travelers. Molecular studies 231 
have shown two YFV genotypes in Uganda, the East African and East/Central African genotypes. 232 
The prevalence and risk of YFV transmission in Uganda varies with the distribution of YFV vectors. 233 
The uneven distribution of YFV across Uganda may be due to the Ae. simpsoni populations. Some 234 
populations of Ae. simpsoni (Ae. bromeliae) mosquitoes from Western Uganda are more 235 
anthropophilic than other Ae. simpsoni (Ae. lilii) populations from other parts of the country (55, 236 
64).  237 
Clinical manifestation in humans vary from mild undifferentiated febrile illness to severe disease 238 
and occurs in two phases (65). The incubation period for YFV varies from 3 to 6 days but 239 
sometimes may go up to 14 days (47). During the infection phase, the virus multiplies and 240 
circulates within the blood. The patient may experience non-specific symptoms such as fever 241 
confused with malaria, typhoid or viral hepatitis (66). When the infection stage enters the 242 
intoxication phase, the virus leaves the blood and replicates in the liver, spleen, heart and lymph 243 
nodes. This phase may be characterized by chills, nausea, anorexia, convulsions, myalgia, 244 
vomiting, dehydration, prostration, hemorrhage, hepatitis with jaundice and central nervous 245 




Zika virus 249 
ZIKV (family: Flaviviridae, genus: Flavivirus), is a mosquito-borne emerging virus related to 250 
dengue virus (DENV), YFV, WNV and Japanese encephalitis virus (JEV) (67). The disease was first 251 
isolated from serum of a sentinel rhesus monkey (Rhesus 766) caged in the canopy of Zika Forest 252 
in Uganda in April 1947 (29). The virus was named after the place where the isolation was made. 253 
The following year in January (1948), it was isolated from a pool of 86 Ae. africanus mosquitoes 254 
caught on a tree platform in Zika Forest (29). Between the time of ZIKV isolation from the caged 255 
rhesus monkey and January when mosquito collections were done and tested, all the remaining 256 
caged 5 rhesus monkeys had developed antibodies to ZIKV (19). A serological survey conducted 257 
around the population living close to the forest and Entebbe region areas revealed ZIKV 258 
antibodies (68). In other areas of the country such as Bwamba county, antibody prevalence to 259 
ZIKV was as high as 20 % (19). Dick demonstrated that ZIKV caused lesions in the skeletal muscles 260 
and myocardial injury in five-day old mice. In 1956, Weinbren isolated a strain of ZIKV from a pool 261 
of Ae. africanus mosquitoes collected from Lunyo Forest (69). Serological surveys through 262 
complement fixation tests confirmed the presence of neutralizing antibodies against ZIKV in 263 
Uganda and Tanzania. Between 1961 and 1963, 12 isolates of the virus were obtained from pools 264 
of Ae. africanus (70). In 1970, McCrae and colleagues isolated ZIKV from a pool of Ae. africanus 265 
and Ae. apicoargenteus mosquitoes collected during the weekly routine collections conducted in 266 
Zika Forest (4). Although no documentation about ZIKV epidemics in Uganda, epizootics had 267 
probably occurred in the Entebbe peninsula in 1948 and 1956, and thereafter several epizootics 268 
were documented in the years 1962 to 1963, and 1969 to 1970 (4, 71). Since then, there have 269 
been no reports about ZIKV, however recent serosurveys suggest evidence of human exposure 270 
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in Central Uganda (72). Reasons for the absence of ZIKV in countries where it was earlier 271 
identified remain poorly understood, however the low infections in humans were partly 272 
attributed to the catholic feeding style of Ae. africanus the principal vector which prefers 273 
monkeys to humans(19). In Africa, where diverse forms of Aedes species exist, limited studies 274 
have been conducted to identify the likely competent vector species, however the virus has on 275 
several occasions been isolated from Ae. africanus a sylvatic mosquito species. Other species 276 
likely to transmit ZIKV include Ae. vitattus, Ae. opok, Ae. bromeliae and Ae. luteocephalus 277 
however few competence experiments have been conducted to confirm whether they are 278 
vectors (67). Outside Africa, an Asian lineage is in existence (73). Many of the issues related to 279 
outbreak in the Americas and Zika congenital syndrome have been expertly reviewed elsewhere 280 
(74, 75) and do not need to be expanded on here. 281 
Rift Valley fever virus  282 
RVFV (family: Phenuiviridae; genus: Phlebovirus) is a re-emerging zoonotic viral disease that 283 
primarily affects ruminants such as goats, sheep and cattle. Infection is characterized by 284 
abortions and still births in adult animals and high mortality in young animals. Animals get 285 
infected through the bite of infected mosquito or tick vectors. Infected young adults may suffer 286 
an acute febrile disease with prostration while the young ruminants grow weak, fail to stand to 287 
suckle and eventually may die within 12 to 24 hours depending on species. Epizootics in animals 288 
are often triggered by persistent heavy rainfall which leads to flooding, which triggers hatching 289 
of infected mosquito populations to initiate RVFV transmission. In Uganda, the first report of 290 
RVFV was in wild mosquitoes collected from Semliki forest, in Western Uganda, during the 291 
collection a dead buffalo and a sick buffalo calf, thought to have been infected with RVFV were 292 
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observed in the catchment area (76). In 1956, Mims reported the presence of RVFV neutralizing 293 
antibodies in Arvicanthis rodents, however further virus isolation attempts contradicted his 294 
findings (71, 77). The second report was a successful virus isolation was from a sampled calf in 295 
Entebbe (71). For over 30 years, little information was documented about RVFV in animals until 296 
2007 when a study done in the Central region revealed 10% RVFV immunoglobulin M (IgM) 297 
neutralizing antibodies in domestic animals (78). These findings were aligned with an outbreak 298 
in 2016 in South-Western Uganda in which a serosurvey revealed that RVFV prevalence was 299 
highest in cattle (26.9%) followed by goats (6.5%) and finally in sheep (5.7%) (79). Between 2016 300 
and 2018, over 10 fatal RVFV outbreaks were reported in domestic animals in over 15 districts, 301 
with spillover into the human population (34, 79). 302 
RVFV was first described in 1930 in Kenya, during that time a new virus named after the Rift 303 
Valley Province of Kenya isolated from sheep was described, later on fatal human cases were 304 
reported in different parts of Kenya (80). During the YFV surveys, a dead red buffalo thought to 305 
have died of RVFV in the mosquito collection area was observed in Bwamba county in 1944. 306 
Entomological studies led to further isolation of RVFV in mosquitoes Ae. tarsalis, Ae. 307 
circumluteolus and Eretmopodites species in the Semliki Forest, Western Uganda (76). The 308 
second successful virus isolation of RVFV was in 1955, from Ae. africanus and Ae. circumluteolus 309 
in Lunyo village, Entebbe (19, 71). Since then, several virus isolations were made from sentinel 310 
collections of Ae. africanus and in 1968 following an outbreak in Entebbe region, RVFV was 311 
isolated from Ma. africana (71). Following the multiple mosquito surveys, Ae. africanus, Ae. 312 
albocephalus, Ae. dendrophilus, E. chrysogaster and E. inornatus Ae. africanus, Ma. africana, Cq. 313 
fuscopennata and Ma. uniformis, Cx. antennatus, Cx. rubinotus, Ae. mcnitoshi, Ae. circumluteolus, 314 
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Ae. tarsalis and Ae. ochraceus are known vectors of RVFV (71, 76) (Figure 1). Despite the 315 
isolations from multiple species, limited competence experiments have been documented to 316 
confirm the vectorial capacity of the diverse mosquito species. 317 
Transmission of RVFV is frequently by Aedes and Culex species. Infected Aedes species lay 318 
infected eggs in small standing pools of water, remaining viable for long periods of drought. 319 
Rainfall and flooding stimulate the eggs to hatch leading to a high infected mosquito population. 320 
The emerging infected Aedes primarily feed on cattle leading to virus amplification, this provides 321 
source of virus for the secondary mosquito vectors, the culicines. As the population of the 322 
infected mosquitoes build up, culicines as well as aedines transmit infection to the susceptible 323 
ruminants such as goats and sheep (81).  324 
In Uganda, historical records show several outbreaks in the human population in the 1950s, many 325 
of these occurred in Western and Central regions of Uganda. From 1960 to 1967, over 8 326 
successful RVFV isolations were made in febrile patients coming from the villages near Entebbe 327 
area reporting to the EAVRI clinic (71). The largest outbreak at the time was in 1968 in the 328 
Entebbe region when RVFV was isolated from 7 febrile patients who had complained of fever, 329 
general body weakness and arthralgia (71). From the 1970s onwards, RVFV remained unreported 330 
in Uganda and the country was classified as a low-risk nation until 2016, when an outbreak 331 
occurred in South-Western Uganda. Infection was confirmed by detection of RVFV RNA in both 332 
human and livestock samples (34). 333 
Humans often get infected when they come into contact with animal tissues and fluids such as 334 
blood, body organs of infected animals, drinking milk from infected animals as well as via 335 
mosquito bites. Within a period of two to six days, it can present as an acute influenza-like illness 336 
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characterized with transient fever, mental confusion, shivering, headache, photophobia, severe 337 
muscle and joint pains, convulsions, hallucinations, anorexia, nausea, vomiting and epistaxis. This 338 
may eventually progress to the hemorrhagic form characterized with liver impairment, jaundice, 339 
vomiting of blood, passing blood in urine and faeces, bleeding in the nose and gums (34, 82) 340 
(Supplementary Table 1). 341 
Although factors responsible for RVFV re-emergence have been extensively investigated 342 
elsewhere, there is limited data on the factors driving the recurrence of RVFV outbreaks in 343 
Uganda however the increased recurrence is partly attributed to livestock movement including 344 
animal products, high density of mosquito vectors and increased El Niño rains (79). More 345 
recently, improved surveillance methods have led to a higher detection frequency of the disease. 346 
RVFV can be identified through detection of antibody IgG and IgM ELISA, detection of virus 347 
antigen by immunofluorescent assays (IFA), virus isolation in cell culture or intracerebral 348 
inoculation of weanling mice, or detection of viral RNA by reverse transcription PCR (RT-PCR). 349 
Chikungunya virus  350 
CHIKV (family: Togaviridae; genus: Alphavirus) is a re-emerging mosquito-borne alphavirus that 351 
belongs to the Semliki Forest group and is serologically related to ONNV (83, 84). Locally, the 352 
word chikungunya is a Tanzanian Kimakonde term which means immobilization of the elbow 353 
joints or “that which folds one up.” The disease due to the bite of an infected Aedes species was 354 
first reported in the Makonde plateau of Tanzania, in 1953 (85). In 1955, CHIKV was isolated from 355 
a mosquito catcher working in Zika Forest in Uganda (39). The victim suffered from an illness 356 
characterized by high fever, headache, coryza, severe pain in the joints and back. It was later 357 
isolated from a pool of 78 Ae. africanus mosquitoes collected on a tree platform in Zika Forest. 358 
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In 1961, a 120 feet steel tower that had been put in Mpanga Forest was transferred to Zika forest 359 
to boost mosquito collections. During those collections on the steel tower, CHIKV virus was 360 
isolated from several Ae. africanus populations, mosquito collectors and febrile patients 361 
reporting at Entebbe clinic where the prevalence of CHIKV was estimated at 2.8% (37). 362 
Transmission occurs following a bite by an infected Aedes mosquito. Once in the human body, 363 
the virus replicates in the skin, disseminates to vital organs including liver, muscle joints, 364 
lymphoid tissue and brain (86). It may remain in blood for five to seven days during which it is 365 
available to re-infect other mosquitoes. Within three to twelve days, the patient may present 366 
with a rapid onset of fever (38.9oC to 40.6oC), often characterized with an irritating maculo-367 
papular rash on the trunk, postorbital pain, severe joint and muscle pain often confused as ONNV 368 
or DENV infection.  369 
 In rural settings where the virus has been described in Uganda, CHIKV circulates in an enzootic 370 
cycle involving sylvatic species such as Ae. africanus and Ae. furcifer, however it has also been 371 
recovered from several other mosquito species including Cq. fuscopenata, Ma. uniformis, Ma. 372 
africana, Ae. taylori and Cx. pipiens fatigans (87, 88). 373 
The disease is one of the most prevalent arboviruses with a seroprevalence of about 46.9% in 374 
North Eastern Uganda, however this magnitude requires careful interpretation as the high 375 
magnitude could be due to the cross reactivity in diagnostics between CHIKV and ONNV which 376 
are closely related and co-circulate within the region (89, 90). In a related study conducted across 377 
the country, the seroprevalence of CHIKV was 31.7% (90). Two outbreaks have been documented 378 
in Uganda, in the Zika Forest in 1968 and in Mukono district in 1982 (84, 91). Since then, little 379 
was heard of CHIKV until recently, when it was described in international travelers coming from 380 
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the Asian countries (92). Over the years, three genotypes with differences in virulence have been 381 
reported in different parts of the world, these include the East/Central/South Africa genotype, 382 
the Asian genotype and the West African genotype (93). In addition to the above genotypes, 383 
recent phylogenetic analyses show multiple CHIKV lineages (94, 95). 384 
O’nyong-nyong virus 385 
ONNV (family: Togaviridae; genus: Alphavirus) causes febrile illness and is characterized by joint 386 
pains hence the name o’nyong-nyong, a Luo term for severe joint pains. The disease was first 387 
described and isolated in 1959 from a 40-year-old female in Northern Uganda presenting with 388 
fever, severe joint pains, backache, headache and anorexia (28). Later, it was isolated from 389 
Anopheles mosquitoes (96). Hemagglutination assays, complement fixation tests and other 390 
serological assays showed cross reactivity of ONNV with CHIKV and SFV (97). Cell culture studies 391 
showed that the virus replicates in various cell types with cytopathic effects in BHK-21 (hamster 392 
kidney) and Vero (green monkey kidney) cells (98). It is estimated that by the end of 1959, over 393 
750,000 people had been infected (99). Between 1959 and 1962, ONNV caused a large outbreak 394 
that spread to cover all the countries in Eastern Africa including Uganda, Kenya, Tanzania, 395 
Malawi, Sudan and Belgian Congo with over 2 million people infected (100). A second outbreak 396 
occurred in South-Western Uganda and spread into Northern Tanzania in 1996 (32, 101). 397 
Seroprevalence studies revealed an infection rate of 121/391 (30.9%), 74 of whom were ONNV 398 
laboratory confirmed while the 47 had presumptive evidence of ONNV infection in the human 399 
population (102). Entomological surveys revealed that An. funestus mosquitoes as the main 400 
vectors for ONNV (101). Serologically, ONNV belongs to the Semliki Forest group and is a variant 401 
of Igbo Ora virus from Nigeria (103). Symptoms for ONNV infection include moderate fever 402 
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(38.9oC) which lasts about five days, a rash which begins from face and extends to the trunk and 403 
hands, swollen lymphadenitis, backache, headache, anorexia, severe joint pains which lasts for a 404 
period of about 6 to 8 days and conjunctivitis (103). 405 
 406 
Current laboratory testing and the role of new next generation platforms in virus discovery 407 
Traditional arbovirus testing includes serology, reverse transcription polymerase chain reaction 408 
(RT-PCR), immunofluorescence assay (IFA) and virus isolation (104). Although these methods are 409 
often used in virus identification, they have limitations. Serology based methods involve testing 410 
for immunoglobulin M antibodies (IgM) which are the first antibody response to virus infection. 411 
Although the method is quite useful in reporting infection to related viruses, it may not 412 
distinguish a previous from active infection, at times give false positives in areas where 413 
vaccination was conducted and often suffer from cross reactivity of closely related viruses (104, 414 
105). Issues of cross reactivity may be overcome by plaque neutralization tests using paired acute 415 
and convalescent samples. Since the former takes a long period of time of close to 14 days, 416 
molecular testing using RT-PCR is often done during outbreak episodes. Although RT-PCR is 417 
sensitive, the method can only detect viruses that have been previously described. 418 
Immunofluorescence assays are conducted using arbovirus grouping fluids or virus specific 419 
antibodies, the method uses fluorophores to identify antigens in infected cells. The challenge 420 
with the method is that use of a monovalent or polyvalent antibody gives results of a related 421 
virus group and therefore further identification is needed. Virus isolation remains a gold standard 422 
and optimal method for identifying a virus. The method involves inoculation of specimen such as 423 
serum or cerebrospinal fluid or crushed tissue on to a confluent monolayer of mammalian or 424 
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insect cell lines to monitor for cytopathic effects (CPE). The challenge with this is cytopathic 425 
effects require careful interpretation as some may result from sample toxicity, which in turn may 426 
result in false positives. Some viruses are undetectable soon after the onset of symptoms, a stage 427 
when antibody titers have risen; and some viruses fail to grow on particular cell lines.  428 
 429 
Strengths and limitations of next generation sequencing in virus discovery 430 
Recent advances in diagnostic tools have accelerated virus discovery and outbreak investigations 431 
in different hosts including arthropod vectors, mammals and humans. Metagenomic next 432 
generation sequencing is a catch-all term for unbiased sequencing using a range of high-433 
throughput technologies. It can be used to detect both previously described and novel pathogens 434 
and does not require prior knowledge of the pathogen genetic sequence (106). In Uganda, it has 435 
been used to discover several new viruses from different animal host and vector species. Four 436 
novel viruses described in Uganda in the last decade were identified using NGS (24-26). Two 437 
(Kibale virus and Mburo virus) out of the four viruses were detected in mosquitoes, while the 438 
other two (Nyangole virus and Ntwetwe virus) were detected in febrile patients. Phylogenetic 439 
studies suggest that some viruses are likely to be vectored not only by mosquitoes but also other 440 
arthropods including ticks and midges. The technology has potential to improve outbreak 441 
investigations to identify pathogens that could otherwise not be detected or investigated, by 442 
using available routine diagnostic tools (27). To give one example, a study detection of emerging 443 
and novel viral infections associated with febrile illnesses in returning travellers was based on 444 
this methodology (25, 107). In areas where mosquitoes feed on different vertebrate hosts, the 445 
tool has also been used to investigate multiple sources of host blood feeding by detecting the 446 
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DNA of the host in the mosquito vector (108). NGS has additionally been used to study the insect 447 
microbiome, which may affect competence of mosquitoes to transmit viruses (109, 110). With 448 
increased human population and related activities in once uninhabited locations, the risk of 449 
zoonotic transmission to humans is high. Therefore, highly sensitive and unbiased tools such as 450 
NGS should be adopted for early virus detection in such “hotspot” areas of zoonotic transmission. 451 
This has the potential to facilitate early containment of outbreaks and development of 452 
appropriate interventions against arboviruses. Further studies are needed to adopt new 453 
diagnostic tools to investigate the role of mosquitoes in the transmission of arboviruses. At 454 
present, the tool remains expensive in terms of reagents, equipment and maintenance especially 455 
for low- and middle-income countries (LMICs). In addition, the large volumes of data generated 456 
by NGS platforms require sophisticated computational infrastructure for storage and analysis. 457 
Nonetheless in time, NGS technologies are likely to be increasingly relevant also in more 458 
challenging settings, and support investigations.  459 
 460 
Conclusion 461 
Historically, there is a high burden and endemicity of arboviruses in Uganda, which we document 462 
here. The majority of these are classified in the family Peribunyaviridae followed by Flaviviridae, 463 
Togaviridae and Phenuiviridae. Viruses in the Reoviridae and Rhabdoviridae families are also 464 
prevalent. Given the many diverse mosquito species already described in Uganda there is a 465 
likelihood of many undescribed mosquito borne viruses. In an era of emerging viruses, some of 466 
which are becoming a global threat, more sensitive tools need to be developed to supplement 467 
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the already existing ones for early detection. The summary provided here will help to give context 468 
to new discoveries and can support research efforts in the future. 469 
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Tables 760 
Table 1: Mosquito-borne arboviruses that have caused outbreaks in Uganda. 761 







BWAV 2 Not known 9%-57.8% (19, 33, 41) 
YFV 8 24.9% 0.97% to 34.2% (10, 27, 57-59, 111) 
ONNV 3 Not known 44% to 61% (32, 101, 112) 
RVFV 13 1% to 2% 10% to 13% (19, 113) 
CHIKV 1 Not known 46.9% (37, 39) 
Abbreviations: BWAV: Bwamba virus, YFV: yellow fever virus, ONNV: o’nyong nyong virus, RVFV: 762 





Table 2: A summary of YFV outbreaks in Uganda. 767 
Year Region, place Animal host Seroprevalence 





Humans  28.6% (10) 
1943 Epizootic on 
Bukasa islands 




Children ≤	4 years 69.8% (114) 





Animals- 36%  
(56) 




Humans 1 fatal case (57) 
1964 Central Uganda, 
Luwawa Forest 
Humans 1 fatal case (58) 




40 % (62) 
 31 
2010 North Eastern 
Uganda, 13 
districts 
Humans 24.9 % (Case 
fatality) 
(40) 





















Figure 1: Mosquito-borne viruses associated with disease in humans, (a) mosquito vectors, (b) 781 
vertebrate hosts 782 






Table S1: Mosquito-borne viruses described in Uganda that are associated with fever/febrile illnesses in humans. 788 
Virus 
name 
Other symptoms Vector species Vertebrate hosts 
and or reservoirs 
References 
WNV Incubation period of 







arthralgia, skin rash 
which may persist up to 
one week, 
Cx. pipiens, Cx. 
quinquefasciatus, 
















An. gambiae and 




Birds, donkeys and 
monkeys. Rodents 






(12, 33, 41) 
BUNV Rash, brain encephalitis, 
arthralgia, stiff neck 









Ma. uniformis, Ma. 
africana 
YFV Incubation period is 3 to 







Ae. africanus, Ae. 
bromeliae sub 











(9, 36, 38, 40, 47) 





















vomiting of blood, 
passing blood in urine 
and faeces, bleeding in 






ZIKV Incubation following 
exposure of about 2 to 
7 days, fever, headache, 
rash, anorexia, 
conjunctivitis, myalgia, 
muscle and joint pains, 
microcephaly and other 
neurodevelopmental 
issues in infants, 
Guillain-Barré 






Monkeys, humans (4, 19, 69, 74, 75) 
CHIKV Incubation following 
exposure 3 to 12 days, 
Ae. africanus, Ae. 
furcifer, Ae. taylori, 
Non-human 
primates 
(5, 37, 39, 47) 
 38 
fever, rash, arthritis, 
itchy rash, headache, 








Mansonia spp, Cx. 
quinquefasciatus 
especially 
monkeys such as 




have also been 
suggested 
ONNV Moderate fever lasting 
about 5 days, 
maculopapular rash 
which erupts 4 to 7 days 
after onset of 
symptoms, joint pains 
An. gambiae and 
An. funestus 









ORUV Headache, myalgia, 
vomiting, conjunctival 
inflammation 





SFV Myalgia, arthralgia, 
headache, brain 
encephalitis, abdominal 
Ae. abnormalis, Ae. 
argenteopunctatus, 






BBKV Arthralgia, joint pains, 
rash and arthritis 





Birds, humans (49) 
SINV Arthralgia, muscle and 
joint pains rash and 
arthritis 
Cx. univitattus, Ma. 
africana 
Birds (49) 
PGAV Joint pains, rash and 
arthritis 
Ae. tarsalis and Cq. 
fuscopennata 
Humans (49, 91) 
GERV Rash and arthritis Cx. rubinotus, Cx. 
theileri 






USUV Rash and arthritis Culex spp Birds, humans, 
cattle and sheep 
(8, 49, 71) 
WSLV Myalgia, arthralgia, 
general body weakness, 
anorexia, headache, 
myalgia, arthralgia, still 






Abbreviations:  WNV: West Nile virus, BWAV: Bwamba virus, BUNV: Bunyamwera virus, YFV: yellow fever virus, RVFV: Rift Valley 789 
fever virus, ZIKV: Zika virus, CHIKV: chikungunya virus, ONNV: o’nyong nyong virus, ORUV: Orungo virus, SFV: Semliki Forest virus, 790 
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